N.B. Bui
-
- Sarcoma Diagnosis and Treatment 17
- Rheumatology top 2%
- Oncology top 2%
- Vascular Tumors and Angiosarcomas 4
- Cancer Treatment and Pharmacology 3
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 6
-
- Lymphoma Diagnosis and Treatment 3
- Soft tissue tumors and treatment 2
-
- Testicular diseases and treatments 2
-
- Chronic Myeloid Leukemia Treatments 2
N.B. Bui
22 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 1.5k
- Rheumatology 573
- Oncology 984
- Cardiology and Cardiovascular Medicine 544
- Gastroenterology 127
Countries citing papers authored by N.B. Bui
This map shows the geographic impact of N.B. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.B. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.B. Bui more than expected).
Fields of papers citing papers by N.B. Bui
This network shows the impact of papers produced by N.B. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.B. Bui. The network helps show where N.B. Bui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N.B. Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 10 | |
| 2 | 2010 | 13 | |
| 3 | 2010 | 25 | |
| 4 | 2010 | 0 | |
| 5 | 2009 | 7 | |
| 6 | 2009 | 2 | |
| 7 | 2009 | 6 | |
| 8 | 2007 | 122 | |
| 9 | 2000 | 15 | |
| 10 | 1998 | 3 | |
| 11 | Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.breakdown → | 1996 | 487 |
| 12 | 1995 | 1 | |
| 13 | 1995 | 3 | |
| 14 | 1993 | 5 | |
| 15 | 1993 | 1 | |
| 16 | 1992 | 41 | |
| 17 | 1992 | 17 | |
| 18 | 1987 | 30 | |
| 19 | 1984 | 5 | |
| 20 | [Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone]. | 1982 | 7 |
About N.B. Bui
N.B. Bui is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Vascular Tumors and Angiosarcomas (4 papers), Cancer Treatment and Pharmacology (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Testicular diseases and treatments (2 papers), Soft tissue tumors and treatment (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Rheumatology (573 citations) and Oncology (984 citations). N.B. Bui has collaborated with scholars based in France, United States and Luxembourg. Frequent co-authors include F. Bonichon, G Contesso, M Trojani, J.‐F. Goussot, C Lagarde, Marc David, Jean‐Michel Coindre, Jacques Rouëssé, A. de Mascarel and J.M. Coindre. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.